Spero Therapeutics (SPRO) EBT Margin Growth (1y) (2017 - 2026)
Spero Therapeutics (SPRO) EBT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Spero Therapeutics |
129.74 Mn |
73.61 Mn |
- |
-255,540.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-255,540.00 |
| Dec 31, 2025 |
-35,192.00 |
| Sep 30, 2025 |
2.67 Mn |
| Jun 30, 2025 |
29,060.00 |
| Mar 31, 2025 |
-9,951.00 |
| Dec 31, 2024 |
-16,520.00 |
| Sep 30, 2024 |
-2.63 Mn |
| Jun 30, 2024 |
13,583.00 |
| Mar 31, 2024 |
581,142.00 |
| Dec 31, 2023 |
-7,918.00 |
| Sep 30, 2023 |
12,026.00 |
| Jun 30, 2023 |
86,457.00 |
| Mar 31, 2023 |
-449,148.00 |
| Dec 31, 2022 |
34,146.00 |
| Sep 30, 2022 |
259,701.00 |
| Jun 30, 2022 |
-42,647.00 |
| Mar 31, 2022 |
-119,205.00 |
| Sep 30, 2021 |
4.68 Mn |
| Jun 30, 2021 |
18,831.00 |
| Mar 31, 2021 |
106,324.00 |
